Eine Auswahl an Publikationen von Prof. Dr. med. Jörg-Dieter Schulzke

Valentini L, Gläser S, Schuetz T, Omar A, Kasim E, Kroencke T, Tietge UJ, Lochs H, Schulzke JD, Brabant G, Ockenga J
Serum bile acids and leptin interact with glucose metabolism in patients with liver cirrhosis.
Clin Nutr 2013; 32(1):122-9.
Schmidt C, Lautenschlaeger C, Collnot EM, Schumann M, Bojarski C, Schulzke JD, Lehr CM, Stallmach A
Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.
J Control Release 2013; 165(2):139-45.
Barmeyer C, Erko I, Fromm A, Bojarski C, Allers K, Moos V, Zeitz M, Fromm M, Schulzke JD
Ion transport and barrier function are disturbed in microscopic colitis.
Ann N Y Acad Sci 2012; 1258:143-8.
Amasheh M, Luettig J, Amasheh S, Zeitz M, Fromm M, Schulzke JD
Effects of quercetin studied in colonic HT-29/B6 cells and rat intestine in vitro.
Ann N Y Acad Sci 2012; 1258:100-7.
Plöger S, Stumpff F, Penner GB, Schulzke JD, Gäbel G, Martens H, Shen Z, Günzel D, Aschenbach JR
Microbial butyrate and its role for barrier function in the gastrointestinal tract.
Ann N Y Acad Sci 2012; 1258:52-9.
Schumann M, Kamel S, Pahlitzsch ML, Lebenheim L, May C, Krauss M, Hummel M, Daum S, Fromm M, Schulzke JD
Defective tight junctions in refractory celiac disease.
Ann N Y Acad Sci 2012; 1258:43-51.
Schulzke JD, Günzel D, John LJ, Fromm M
Perspectives on tight junction research.
Ann N Y Acad Sci 2012; 1257::1-19.
Hering NA, Fromm M, Schulzke JD
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.
J Physiol 2012; 190:1035-44.

Kontakt

Bitte wenden Sie sich an Frau
Birgit Röders
t: +49 30 8445 2820

Mehr...